Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic Prophylaxis

Cytomegalovirus (CMV) infection is the most common opportunistic infection that occurs following orthotopic liver transplantation (OLT). In addition to the direct infection-related symptoms, it also triggers an immunological response that may contribute to adverse clinical outcomes. CMV disease has...

Full description

Bibliographic Details
Main Authors: Robert Breitkopf, Benedikt Treml, Zoran Bukumiric, Nicole Innerhofer, Margot Fodor, Aleksandra Radovanovic Spurnic, Sasa Rajsic
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/16/5198
_version_ 1797584326389399552
author Robert Breitkopf
Benedikt Treml
Zoran Bukumiric
Nicole Innerhofer
Margot Fodor
Aleksandra Radovanovic Spurnic
Sasa Rajsic
author_facet Robert Breitkopf
Benedikt Treml
Zoran Bukumiric
Nicole Innerhofer
Margot Fodor
Aleksandra Radovanovic Spurnic
Sasa Rajsic
author_sort Robert Breitkopf
collection DOAJ
description Cytomegalovirus (CMV) infection is the most common opportunistic infection that occurs following orthotopic liver transplantation (OLT). In addition to the direct infection-related symptoms, it also triggers an immunological response that may contribute to adverse clinical outcomes. CMV disease has been described as a predictor of invasive fungal infections (IFIs) but its role under an antiviral prophylaxis regimen is unclear. Methods: We retrospectively analyzed the medical records of 214 adult liver transplant recipients (LTRs). Universal antiviral prophylaxis was utilized in recipients with CMV mismatch; intermediate- and low-risk patients received pre-emptive treatment. Results: Six percent of patients developed CMV disease independent of their serostatus. The occurrence of CMV disease was associated with elevated virus load and increased incidence of leucopenia and IFIs. Furthermore, CMV disease was associated with higher one-year mortality and increased relapse rates within the first year of OLT. Conclusions: CMV disease causes significant morbidity and mortality in LTRs, directly affecting transplant outcomes. Due to the increased risk of IFIs, antifungal prophylaxis for CMV disease may be appropriate. Postoperative CMV monitoring should be considered after massive transfusion, even in low-risk serostatus constellations. In case of biliary complications, biliary CMV monitoring may be appropriate in the case of CMV-DNA blood-negative patients.
first_indexed 2024-03-10T23:50:16Z
format Article
id doaj.art-3e8a18ff1a6e48f19005aee55c93115f
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T23:50:16Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-3e8a18ff1a6e48f19005aee55c93115f2023-11-19T01:39:22ZengMDPI AGJournal of Clinical Medicine2077-03832023-08-011216519810.3390/jcm12165198Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic ProphylaxisRobert Breitkopf0Benedikt Treml1Zoran Bukumiric2Nicole Innerhofer3Margot Fodor4Aleksandra Radovanovic Spurnic5Sasa Rajsic6Department of Anesthesia and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, AustriaDepartment of Anesthesia and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, AustriaInstitute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, SerbiaDepartment of Anesthesia and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, AustriaDepartment of Visceral, Transplantation and Thoracic Surgery, Medical University of Innsbruck, 6020 Innsbruck, AustriaClinic for Infectious and Tropical Diseases, University Clinical Centre of Serbia, 11000 Belgrade, SerbiaDepartment of Anesthesia and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, AustriaCytomegalovirus (CMV) infection is the most common opportunistic infection that occurs following orthotopic liver transplantation (OLT). In addition to the direct infection-related symptoms, it also triggers an immunological response that may contribute to adverse clinical outcomes. CMV disease has been described as a predictor of invasive fungal infections (IFIs) but its role under an antiviral prophylaxis regimen is unclear. Methods: We retrospectively analyzed the medical records of 214 adult liver transplant recipients (LTRs). Universal antiviral prophylaxis was utilized in recipients with CMV mismatch; intermediate- and low-risk patients received pre-emptive treatment. Results: Six percent of patients developed CMV disease independent of their serostatus. The occurrence of CMV disease was associated with elevated virus load and increased incidence of leucopenia and IFIs. Furthermore, CMV disease was associated with higher one-year mortality and increased relapse rates within the first year of OLT. Conclusions: CMV disease causes significant morbidity and mortality in LTRs, directly affecting transplant outcomes. Due to the increased risk of IFIs, antifungal prophylaxis for CMV disease may be appropriate. Postoperative CMV monitoring should be considered after massive transfusion, even in low-risk serostatus constellations. In case of biliary complications, biliary CMV monitoring may be appropriate in the case of CMV-DNA blood-negative patients.https://www.mdpi.com/2077-0383/12/16/5198cytomegalovirusinvasive fungal infectionsliver transplantationserostatusvirus load
spellingShingle Robert Breitkopf
Benedikt Treml
Zoran Bukumiric
Nicole Innerhofer
Margot Fodor
Aleksandra Radovanovic Spurnic
Sasa Rajsic
Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic Prophylaxis
Journal of Clinical Medicine
cytomegalovirus
invasive fungal infections
liver transplantation
serostatus
virus load
title Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic Prophylaxis
title_full Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic Prophylaxis
title_fullStr Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic Prophylaxis
title_full_unstemmed Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic Prophylaxis
title_short Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic Prophylaxis
title_sort cytomegalovirus disease as a risk factor for invasive fungal infections in liver transplant recipients under targeted antiviral and antimycotic prophylaxis
topic cytomegalovirus
invasive fungal infections
liver transplantation
serostatus
virus load
url https://www.mdpi.com/2077-0383/12/16/5198
work_keys_str_mv AT robertbreitkopf cytomegalovirusdiseaseasariskfactorforinvasivefungalinfectionsinlivertransplantrecipientsundertargetedantiviralandantimycoticprophylaxis
AT benedikttreml cytomegalovirusdiseaseasariskfactorforinvasivefungalinfectionsinlivertransplantrecipientsundertargetedantiviralandantimycoticprophylaxis
AT zoranbukumiric cytomegalovirusdiseaseasariskfactorforinvasivefungalinfectionsinlivertransplantrecipientsundertargetedantiviralandantimycoticprophylaxis
AT nicoleinnerhofer cytomegalovirusdiseaseasariskfactorforinvasivefungalinfectionsinlivertransplantrecipientsundertargetedantiviralandantimycoticprophylaxis
AT margotfodor cytomegalovirusdiseaseasariskfactorforinvasivefungalinfectionsinlivertransplantrecipientsundertargetedantiviralandantimycoticprophylaxis
AT aleksandraradovanovicspurnic cytomegalovirusdiseaseasariskfactorforinvasivefungalinfectionsinlivertransplantrecipientsundertargetedantiviralandantimycoticprophylaxis
AT sasarajsic cytomegalovirusdiseaseasariskfactorforinvasivefungalinfectionsinlivertransplantrecipientsundertargetedantiviralandantimycoticprophylaxis